Literature DB >> 18322765

[Generics in Austria 2003-2008: an update].

Markus Müller.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18322765     DOI： 10.1007/s00508-008-0926-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

1.  [Generic drugs--medical progress at a moderate price].

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

2.  [Cost reduction with project based prescription of generic ACE inhibitors].

Authors:  Michael Wolzt; Gerald Ohrenberger; Berthold Reichardt
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

3.  Biosimilars: initial excitement gives way to reality.

Authors:  Mark J Belsey; Laura M Harris; Romita R Das; Joanna Chertkow
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

4.  Pharma companies becoming more aggressive towards generics firms.

Authors:  Simon Frantz
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

5.  Biological therapies: concepts and challenges.

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

6.  [Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients].

Authors:  Ghazaleh Gouya; Berthold Reichardt; Anja Bidner; Robert Weissenfels; Michael Wolzt
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

7.  The ongoing regulation of generic drugs.

Authors:  Richard G Frank
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

8.  Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

Authors:  Sebastian Schneeweiss; Alexander M Walker; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Stephen B Soumerai
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

9.  [Generic drugs: quality, efficacy, safety and interchangeability].

Authors:  Doris Tschabitscher; Peter Platzer; Christoph Baumgärtel; Marcus Müllner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704
  9 in total
  1 in total

1.  [Measures to reduce costs for prescriptions in Vienna--preliminary analysis].

Authors:  Hans Tönies
Journal:  Wien Med Wochenschr       Date:  2009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.